Used as a key intermediate in pharmaceutical synthesis, particularly in the preparation of kinase inhibitors for targeted cancer therapies. Its boronic acid functionality enables Suzuki-Miyaura cross-coupling reactions, allowing efficient construction of complex heterocyclic systems found in bioactive molecules. Commonly employed in research and development of oncology drugs due to its stability and reactivity under mild conditions. Also utilized in medicinal chemistry for fragment-based drug design and library synthesis in high-throughput screening programs.